Private Medicare plans must cover Biogen’s ALS drug, US agency says

(Reuters) – The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen (NASDAQ:BIIB)’s amyotrophic lateral sclerosis drug Qalsody after finding instances of coverage denial. Qalsody received the U.S. Food and Drug Administration’s accelerated approval last year, but CMS said it found many Medicare Advantage plans, which cover…

Read More

Blackrock recommends bitcoin portfolio weighting of up to 2% for interested investors

By Suzanne McGee (Reuters) – Blackrock (NYSE:BLK) recommends that interested investors consider allocating as much as 2% of their portfolio to bitcoin, the world’s largest cryptocurrency, the giant asset manager said in a report on Thursday. “We see a case for investors with suitable governance and risk tolerance to include bitcoin in a multi-asset portfolio,”…

Read More

Chanel picks Matthieu Blazy as creative director – reports

PARIS (Reuters) -French fashion house Chanel selected former Bottega Veneta design chief Matthieu Blazy as its next creative director, Women’s Wear Daily and the Financial Times reported Thursday. French luxury group Kering (EPA:PRTP) earlier said it has appointed Louise Trotter as creative director of its Bottega Veneta brand to replace Blazy, whose name has been…

Read More

Intel executives say manufacturing spinoff is possible

(Reuters) – The two executives leading Intel (NASDAQ:INTC) after the ouster of its chief executive said on Thursday that the company may spin out its manufacturing division. Speaking at an investment banking conference, Co-Chief Executive Michelle Johnston Holthaus said she did not think would make sense to fully separate the company’s product and manufacturing divisions…

Read More